Recarbio

Merck’s Recarbrio Shows Success in Late-Stage Trial for HABP/VABP Patients
BioSpace
Tue, 10/1/19 - 12:10 am
Merck
Recarbio
HABP/VABP
hospital-acquired bacterial pneumonia